Musculoskeletal Physiotherapy High Impact Factor Journals
Musculoskeletal
Physiotherapy involves the treatment of disorders that affect how you progress – how your muscles and joints work together. Whether it’s your feet, ankles and legs, your hands, arms and shoulders, or your backs and necks – an injury that makes it painful or difficult to move can have a big impact on your life. Physiotherapists are specialists within the management of movement disorders. We will talk with you, observe your movement and use a hands-on assessment to gauge your problem. We will take the time to elucidate your diagnosis and develop a treatment plan.
Physiotherapy helps restore movement and performance when someone is suffering from injury, illness or disability.
Physiotherapy can help with back pain, sudden injury and long-term medical conditions also as childbirth and sporting injuries. They maintain
health for people of all ages, helping patients to manage pain and stop disease. The profession helps to encourage development and facilitate recovery, enabling people to stay in work while helping them to remain independent for as long as possible. The document brings together key evidence from the NIHR demonstrating that investment in
physiotherapy services for
musculoskeletal conditions improves patient outcomes and reduces healthcare costs. It highlights
physiotherapy interventions recommended by NICE and Public
Health England.
High Impact List of Articles
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Microbiological Approach in Diagnosing Native and Heart Valves Prosthesis Infections
Carla Fontana, Marco Favaro, Pasquale Sordillo, Cesare Sarrecchia, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Cartesio Favalli
Research Paper: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1: an update
K Nicole Weaver, Gregory A Grabowski & Thomas A Burrow
Drug Evaluation: Clinical Investigation
-
Oral iron therapies in development for iron deficiency in chronic kidney disease
David William Mudge & David Wayne Johnson
Clinical Trail Outcomes: Clinical Investigation
-
Oral iron therapies in development for iron deficiency in chronic kidney disease
David William Mudge & David Wayne Johnson
Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implications of BRCA1 and BRCA2 status for cancer clinical study outcomes
Alan Christie, David Cameron & Charlie Gourley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of high-risk neuroblastoma in children: recent clinic trial results
Emily Greengard,Christine Hill-Kayser,Rochelle Bagatell
Review: Clinical Trail Outcomes: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
Relevant Topics in Clinical